Peter F. Coccia

9.4k total citations
108 papers, 5.7k citations indexed

About

Peter F. Coccia is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Oncology. According to data from OpenAlex, Peter F. Coccia has authored 108 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Public Health, Environmental and Occupational Health, 35 papers in Hematology and 25 papers in Oncology. Recurrent topics in Peter F. Coccia's work include Acute Lymphoblastic Leukemia research (45 papers), Lymphoma Diagnosis and Treatment (22 papers) and Acute Myeloid Leukemia Research (17 papers). Peter F. Coccia is often cited by papers focused on Acute Lymphoblastic Leukemia research (45 papers), Lymphoma Diagnosis and Treatment (22 papers) and Acute Myeloid Leukemia Research (17 papers). Peter F. Coccia collaborates with scholars based in United States, Canada and Switzerland. Peter F. Coccia's co-authors include Mark E. Nesbit, Sarah E. Strandjord, Harland N. Sather, Ulla M. Saarinen, Stuart E. Siegel, Nai‐Kong V. Cheung, William Krivit, John H. Kersey, Norma K.C. Ramsay and Hillard M. Lazarus and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Peter F. Coccia

107 papers receiving 5.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter F. Coccia United States 44 1.7k 1.7k 1.5k 1.3k 1.1k 108 5.7k
Howard J. Weinstein United States 43 1.6k 0.9× 2.2k 1.3× 1.2k 0.8× 850 0.7× 736 0.7× 122 5.4k
Raymond J. Hutchinson United States 42 1.9k 1.1× 1.6k 0.9× 1.3k 0.8× 897 0.7× 1.5k 1.4× 136 5.6k
Bruce Bostrom United States 44 2.9k 1.7× 2.1k 1.2× 1.1k 0.7× 1.2k 0.9× 1.9k 1.7× 129 6.0k
James B. Nachman United States 44 4.3k 2.5× 2.6k 1.5× 1.3k 0.8× 869 0.7× 2.7k 2.5× 125 6.9k
J. S. Malpas United Kingdom 36 815 0.5× 1.7k 1.0× 1.9k 1.3× 1.4k 1.1× 308 0.3× 109 5.5k
Donald Pinkel United States 34 1.9k 1.1× 1.2k 0.7× 1.1k 0.7× 598 0.5× 1.2k 1.1× 122 4.5k
Joseph Mirro United States 35 2.0k 1.2× 2.7k 1.6× 822 0.5× 1.2k 1.0× 497 0.5× 93 4.7k
F R Appelbaum United States 47 1.3k 0.7× 6.0k 3.4× 2.9k 1.9× 847 0.7× 562 0.5× 99 8.5k
Joseph Brandwein Canada 40 1.2k 0.7× 2.7k 1.6× 1.8k 1.2× 1.8k 1.4× 646 0.6× 191 5.3k
Teresa J. Vietti United States 43 981 0.6× 736 0.4× 2.2k 1.4× 1.4k 1.1× 777 0.7× 149 8.0k

Countries citing papers authored by Peter F. Coccia

Since Specialization
Citations

This map shows the geographic impact of Peter F. Coccia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter F. Coccia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter F. Coccia more than expected).

Fields of papers citing papers by Peter F. Coccia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter F. Coccia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter F. Coccia. The network helps show where Peter F. Coccia may publish in the future.

Co-authorship network of co-authors of Peter F. Coccia

This figure shows the co-authorship network connecting the top 25 collaborators of Peter F. Coccia. A scholar is included among the top collaborators of Peter F. Coccia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter F. Coccia. Peter F. Coccia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rodgers, George M., Pamela S. Becker, Morey A. Blinder, et al.. (2012). Cancer- and Chemotherapy-Induced Anemia. Journal of the National Comprehensive Cancer Network. 10(5). 628–653. 171 indexed citations
2.
Hodges, Emily, et al.. (1994). Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation.. Journal of Clinical Oncology. 12(9). 1917–1922. 66 indexed citations
3.
Tubergen, D G, Gerald S. Gilchrist, Richard T. O’Brien, et al.. (1993). Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.. Journal of Clinical Oncology. 11(3). 520–526. 107 indexed citations
4.
Tubergen, D G, Gerald S. Gilchrist, Richard T. O’Brien, et al.. (1993). Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.. Journal of Clinical Oncology. 11(3). 527–537. 167 indexed citations
5.
Bleyer, W. Archie, Harland N. Sather, H. James Nickerson, et al.. (1991). Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.. Journal of Clinical Oncology. 9(6). 1012–1021. 52 indexed citations
6.
Gordon, Bruce G., et al.. (1991). Successful Treatment of Severe Aplastic Anemia by Bone Marrow Transplantation from HLA Nonidentical Family Members. Journal of Pediatric Hematology/Oncology. 13(1). 29–33. 2 indexed citations
7.
Meadows, Anna T., Richard Sposto, R. D. T. Jenkin, et al.. (1989). Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study Group.. Journal of Clinical Oncology. 7(1). 92–99. 54 indexed citations
8.
Wilson, John F., Carl R. Kjeldsberg, Richard Sposto, et al.. (1987). The pathology of non-Hodgkin's lymphoma of childhood: II. Reproducibility and relevance of the histologic classification of “undifferentiated” lymphomas (Burkitt's versus non-Burkitt's). Human Pathology. 18(10). 1008–1014. 20 indexed citations
9.
Hammond, Denman, Harland N. Sather, Mark E. Nesbit, et al.. (1986). Analysis of prognostic factors in acute lymphoblastic leukemia. Medical and Pediatric Oncology. 14(3). 124–134. 105 indexed citations
10.
Gordon, Erlinda M., et al.. (1985). Reduction of contact factors in sickle cell disease. The Journal of Pediatrics. 106(3). 427–430. 17 indexed citations
11.
Saarinen, Ulla M., Peter F. Coccia, Stanton L. Gerson, Robert Pelley, & Nai‐Kong V. Cheung. (1985). Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow.. PubMed. 45(11 Pt 2). 5969–75. 61 indexed citations
12.
Cheung, Nai‐Kong V., et al.. (1984). USE OF MONOCLONAL ANTIBODIES SPECIFIC FOR NEUROBLASTOMA (NB) IN THE DETECTION AND COMPLEMENT MEDIATED LYSIS OF MICROSCOPIC DISEASE. Pediatric Research. 18. 237A–237A. 1 indexed citations
13.
Gordon, Erlinda M., Robert J. Berkowitz, Sarah E. Strandjord, et al.. (1983). Burkitt lymphoma in a patient with classic hemophilia receiving factor VIII concentrates. The Journal of Pediatrics. 103(1). 75–77. 19 indexed citations
14.
Gross, Samuel, Stuart E. Siegel, Peter F. Coccia, W. Archie Bleyer, & D Hammond. (1980). A toxicity study of cyclophosphamide in combination induction therapy in childhood acute lymphocytic leukemia. A report for childrens cancer study group. Journal of Pediatric Hematology/Oncology. 2(4). 321–325. 2 indexed citations
15.
Shapiro, Ralph, Jonathan M. Gerrard, Norma K.C. Ramsay, et al.. (1980). Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy.. PubMed. 2(3). 207–12. 14 indexed citations
16.
Leikin, Sanford, Vincent Albo, Harland N. Sather, et al.. (1980). Use of prognostic factors in improving the design and efficiency of clinical trials in childhood leukemia: Children's Cancer Study Group Report.. PubMed. 64(2-3). 381–92. 42 indexed citations
17.
Kersey, JH, Tucker W. LeBien, Richard L. Hurwitz, et al.. (1979). Childhood leukemia-lymphoma. Heterogeneity of phenotypes and prognoses.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(4 Suppl). 746–52. 26 indexed citations
18.
Brunning, Richard D., Robert W. McKenna, Clara D. Bloomfield, Peter F. Coccia, & Kazimiera J. Gajl‐Peczalska. (1977). Bone marrow involvement in Burkitt's lymphoma. Cancer. 40(4). 1771–1779. 24 indexed citations
19.
Coccia, Peter F., et al.. (1976). Prognostic significance of surface marker analysis in childhood non‐hodgkin's lymphoproliferative malignancies. American Journal of Hematology. 1(4). 405–417. 43 indexed citations
20.
Coccia, Peter F. & W.W. Westerfeld. (1967). THE METABOLISM OF CHLORPROMAZINE BY LIVER MICROSOMAL ENZYME SYSTEMS. Journal of Pharmacology and Experimental Therapeutics. 157(2). 446–458. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026